FERRI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 134
EU - Europa 119
AS - Asia 92
SA - Sud America 31
OC - Oceania 6
Totale 382
Nazione #
US - Stati Uniti d'America 107
SG - Singapore 59
IT - Italia 42
BR - Brasile 30
DE - Germania 28
CA - Canada 22
CN - Cina 13
IE - Irlanda 8
FI - Finlandia 7
FR - Francia 7
AU - Australia 6
BZ - Belize 5
ES - Italia 5
GB - Regno Unito 5
AT - Austria 4
KR - Corea 4
TR - Turchia 4
NL - Olanda 3
PL - Polonia 3
VN - Vietnam 3
EE - Estonia 2
IL - Israele 2
IR - Iran 2
RU - Federazione Russa 2
SE - Svezia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
EC - Ecuador 1
GE - Georgia 1
GR - Grecia 1
IN - India 1
SA - Arabia Saudita 1
Totale 382
Città #
Singapore 49
Houston 15
New York 15
Montreal 14
Nuremberg 13
Pescara 12
Chandler 8
Dublin 8
Santa Clara 8
Naples 7
Tongling 7
The Dalles 6
Lappeenranta 5
Toronto 5
Jundiaí 4
Rochester 4
Alba 3
Falkenstein 3
Los Angeles 3
Melbourne 3
Prato 3
Princeton 3
Saskatoon 3
Ancona 2
Ankara 2
Aprilia 2
Curitiba 2
Düsseldorf 2
Frankfurt am Main 2
Helsinki 2
Islington 2
Lauterbourg 2
Munich 2
Ness Ziona 2
Piotrkow Trybunalski 2
Rome 2
San Cristóbal de La Laguna 2
Santander 2
Shanghai 2
São José 2
Vienna 2
Adelaide 1
Antalya 1
Ascoli Piceno 1
Ashburn 1
Athens 1
Baku 1
Bari 1
Birmingham 1
Biên Hòa 1
Blumenau 1
Boardman 1
Brisbane 1
Brooklyn 1
Catuji 1
Charlotte 1
Chennai 1
Chicago 1
Clarksburg 1
Coronel Fabriciano 1
Cuiabá 1
Dallas 1
Divinópolis 1
Giresun 1
Guangzhou 1
Guarulhos 1
Heidelberg 1
Ho Chi Minh City 1
Hoffman 1
Horizonte 1
Hwaseong-si 1
Indianópolis 1
Kurrara 1
London 1
Louisville 1
Macapá 1
Manchester 1
Montesilvano Marina 1
New City 1
Nova Olinda 1
Oklahoma City 1
Paderborn 1
Paulínia 1
Penápolis 1
Ponte Nova 1
Quito 1
Quixadá 1
Quận Bình Thạnh 1
Raleigh 1
Recreio 1
Riesi 1
Rio de Janeiro 1
Rondonópolis 1
Saarbrücken 1
Saint-Saens 1
Salvador 1
San Francisco 1
Santa Fe 1
Spring 1
St Louis 1
Totale 296
Nome #
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 132
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 50
Specialized pro-resolving lipid mediators and resolution of viral diseases 41
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy 30
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis 30
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 28
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis 26
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis 26
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment 26
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES 19
Totale 408
Categoria #
all - tutte 2.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.188


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 0 0 2
2022/202321 1 2 1 1 2 5 1 1 4 0 3 0
2023/2024110 6 4 1 2 3 9 2 29 7 24 14 9
2024/2025247 13 30 19 6 48 6 22 24 9 20 21 29
2025/202628 28 0 0 0 0 0 0 0 0 0 0 0
Totale 408